TSXV - Delayed Quote • CAD
Aequus Pharmaceuticals Inc. (AQS.V)
At close: April 17 at 9:30 AM EDT
Key Executives
Amounts are as of December 31, 2022 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in CAD.
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
| Mr. Douglas Glen Janzen | Chairman, CEO & President | 206.25k | -- | 1969 |
| Ms. Ann Fehr CGA, CPA | CFO & Corporate Secretary | 136.13k | -- | 1969 |
| Mr. Grant Larsen | Chief Commercial Officer | 244.58k | -- | -- |
Aequus Pharmaceuticals Inc.
200 Granville Street
Suite 2820
Vancouver, BC V6C 1S4
Canada
- Sector:
- Healthcare
- Industry: Drug Manufacturers - Specialty & Generic
- Full Time Employees:
- 12
Description
Aequus Pharmaceuticals Inc. operates as a specialty pharmaceutical company in Canada. The company markets ZIMED PF, a preservative-free bimatoprost ophthalmic solution. It also develops a range of prescription-free dry eye products under the OPTASE name; and REV-0100 for the treatment of stargardt disease. The company was incorporated in 2013 and is headquartered in Vancouver, Canada.
Corporate Governance
Aequus Pharmaceuticals Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.
Recent Events
Recent Events Information Not Available
Upcoming Events
Apr 29, 2024 - May 03, 2024
Aequus Pharmaceuticals Inc. Earnings Call
Related Tickers
MPH.V Medicure Inc.
1.0300
-4.63%
NU.V NeutriSci International Inc.
0.0050
0.00%
MDP.TO Medexus Pharmaceuticals Inc.
1.5500
+2.65%
LOVE.V Cannara Biotech Inc.
0.8700
0.00%
OPTN OptiNose, Inc.
0.9277
-9.05%
ENTG.V Entourage Health Corp.
0.0100
0.00%
MMNFF MedMen Enterprises Inc.
0.0000
0.00%
TLPH Talphera, Inc.
1.0400
+2.97%
GUD.TO Knight Therapeutics Inc.
5.79
-1.19%
TLRY.TO Tilray Brands, Inc.
2.3900
+0.84%